Quick Answer
COLLEGIUM PHARMACEUTICAL, INC reported Net Income Loss of $62.87 million for the year ending 2025.
- COLLEGIUM PHARMACEUTICAL, INC showed a decrease of -9.1% in Net Income Loss from 2024 to 2025.
- This data is from COLLEGIUM PHARMACEUTICAL, INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 13 years of available data (2013 to 2025), COLLEGIUM PHARMACEUTICAL, INC's Net Income Loss has grown by 488.2%.
- Historical annual values: Fiscal year 2025: $62.87 million | Fiscal year 2024: $69.19 million | Fiscal year 2023: $48.16 million | Fiscal year 2022: -$25.00 million | Fiscal year 2021: $71.52 million | Fiscal year 2020: $26.75 million | Fiscal year 2019: -$22.72 million | Fiscal year 2018: -$39.13 million | Fiscal year 2017: -$74.87 million | Fiscal year 2016: -$94.18 million | Fiscal year 2015: -$27.26 million | Fiscal year 2014: -$17.92 million | Fiscal year 2013: -$16.20 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: